Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Leukemia
|
May 7, 2015
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T Bernal, P Martínez-Camblor, J Sánchez-García, et al.
Leukemia Research
|
August 21, 2014
Results of allogeneic stem cell transplantation in the Spanish MDS registry: prognostic factors for low risk patients
M Díez Campelo, M Sánchez-Barba, V Gómez-García de Soria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy
Pau Montesinos, José D González, José González, et al.
British Journal of Haematology
|
May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia
Ana M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
Leukemia & Lymphoma
|
June 14, 2021
Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients
Blanca Boluda, David Martínez-Cuadrón, Lorenzo Algarra, et al.
Cancer
|
June 19, 2024
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry
Jorge Labrador, David Martínez-Cuadrón, Blanca Boluda, et al.
Annals of Hematology
|
June 17, 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
E U Suárez, B Boluda, E Lavilla, et al.
Leukemia
|
October 20, 2020
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, et al.
Cancer
|
April 10, 2026
Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry
Juan M Alonso-Dominguez, Tamara Castaño-Bonilla, Cristina Gil, et al.
Cancers
|
June 10, 2022
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia
David Martínez-Cuadrón, Josefina Serrano, José Mariz, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Leukemia
|
May 7, 2015
Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
T Bernal, P Martínez-Camblor, J Sánchez-García, et al.
Leukemia Research
|
August 21, 2014
Results of allogeneic stem cell transplantation in the Spanish MDS registry: prognostic factors for low risk patients
M Díez Campelo, M Sánchez-Barba, V Gómez-García de Soria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy
Pau Montesinos, José D González, José González, et al.
British Journal of Haematology
|
May 26, 2018
Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia
Ana M Hurtado, Gines Luengo-Gil, Tzu H Chen-Liang, et al.
Leukemia & Lymphoma
|
June 14, 2021
Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients
Blanca Boluda, David Martínez-Cuadrón, Lorenzo Algarra, et al.
Cancer
|
June 19, 2024
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry
Jorge Labrador, David Martínez-Cuadrón, Blanca Boluda, et al.
Annals of Hematology
|
June 17, 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
E U Suárez, B Boluda, E Lavilla, et al.
Leukemia
|
October 20, 2020
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?
David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, et al.
Cancer
|
April 10, 2026
Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry
Juan M Alonso-Dominguez, Tamara Castaño-Bonilla, Cristina Gil, et al.
Cancers
|
June 10, 2022
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory <i>FLT3</i>-ITD Mutation-Positive Acute Myeloid Leukemia
David Martínez-Cuadrón, Josefina Serrano, José Mariz, et al.
Page
of 8